147 related articles for article (PubMed ID: 9890457)
1. Oral mucosal leishmaniasis as a presenting feature of HIV infection and its management.
Chaudhry Z; Barrett AW; Corbett E; French PD; Zakrzewska JM
J Oral Pathol Med; 1999 Jan; 28(1):43-6. PubMed ID: 9890457
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of oral leishmaniasis--case series and literature review.
Nadler C; Enk CD; Leon GT; Samuni Y; Maly A; Czerninski R
J Oral Maxillofac Surg; 2014 May; 72(5):927-34. PubMed ID: 24480757
[TBL] [Abstract][Full Text] [Related]
3. Leishmaniasis presenting to the otolaryngologist: a rare but important cause of persistent hoarseness.
Santangeli L; McCluney NA; Hathorn I; Shakeel M; Anderson C
J Laryngol Otol; 2009 Oct; 123(10):1181-3. PubMed ID: 19128519
[TBL] [Abstract][Full Text] [Related]
4. American cutaneous leishmaniasis.
Freeman K
J R Army Med Corps; 1983 Oct; 129(3):167-73. PubMed ID: 6319690
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic dilemma of primary mucosal leishmaniasis.
Al-Qahtani MS; Malik NW; Jamil S; Mekki TE
Saudi Med J; 2012 Nov; 33(11):1234-8. PubMed ID: 23147884
[TBL] [Abstract][Full Text] [Related]
6. Mucosal leishmaniasis in a Sudanese patient.
Abbas K; Musatafa MA; Abass S; Kheir MM; Mukhtar M; Elamin EM; Elhassan AM
Am J Trop Med Hyg; 2009 Jun; 80(6):935-8. PubMed ID: 19478252
[TBL] [Abstract][Full Text] [Related]
7. Leishmaniasis.
Herwaldt BL
Lancet; 1999 Oct; 354(9185):1191-9. PubMed ID: 10513726
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of visceral leishmaniasis in Finnish-type congenital nephrotic syndrome.
Grech V; Vella C; Parascandolo R
Pediatr Nephrol; 2000 May; 14(5):410-1. PubMed ID: 10805470
[TBL] [Abstract][Full Text] [Related]
9. Oral leishmaniasis in an HIV-positive patient caused by two different zymodemes of Leishmania infantum.
Cortés P; Cardeñosa N; Romaní J; Gállego M; Muñoz C; Barrio JL; Riera C; Portús M
Trans R Soc Trop Med Hyg; 1997; 91(4):438-9. PubMed ID: 9373646
[No Abstract] [Full Text] [Related]
10. Leishmaniasis and its relevance to UK Armed Forces.
Preedy HC; Bailey MS
J R Nav Med Serv; 2014; 100(3):238-43. PubMed ID: 25895401
[TBL] [Abstract][Full Text] [Related]
11. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
Collini P; Premchand N; Lockwood D; Greig J
Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915
[No Abstract] [Full Text] [Related]
12. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience.
Aronson NE; Wortmann GW; Johnson SC; Jackson JE; Gasser RA; Magill AJ; Endy TP; Coyne PE; Grogl M; Benson PM; Beard JS; Tally JD; Gambel JM; Kreutzer RD; Oster CN
Clin Infect Dis; 1998 Dec; 27(6):1457-64. PubMed ID: 9868660
[TBL] [Abstract][Full Text] [Related]
14. Leishmaniasis.
Evans TG
Infect Dis Clin North Am; 1993 Sep; 7(3):527-46. PubMed ID: 8254158
[TBL] [Abstract][Full Text] [Related]
15. Leishmaniasis in HIV infection.
Paredes R; Munoz J; Diaz I; Domingo P; Gurgui M; Clotet B
J Postgrad Med; 2003; 49(1):39-49. PubMed ID: 12865570
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous leishmaniasis of the ear muscle. A case report].
Negri B; Haberl R; Neubert U; Wilmes E
Laryngorhinootologie; 1990 May; 69(5):281-4. PubMed ID: 2162178
[TBL] [Abstract][Full Text] [Related]
17. Leishmaniasis (PKDL) as a case of immune reconstitution inflammatory syndrome (IRIS) in HIV-positive patient after initiation of anti-retroviral therapy (ART).
Tadesse A; Hurissa Z
Ethiop Med J; 2009 Jan; 47(1):77-9. PubMed ID: 19743785
[TBL] [Abstract][Full Text] [Related]
18. Co-infection of mucosal leishmaniasis and extra pulmonary tuberculosis in a patient with inherent immune deficiency.
Rathnayake D; Ranawake RR; Sirimanna G; Siriwardhane Y; Karunaweera N; De Silva R
Int J Dermatol; 2010 May; 49(5):549-51. PubMed ID: 20534090
[TBL] [Abstract][Full Text] [Related]
19. The chemotherapy of protozoal infections: whither?
Steck EA
J Protozool; 1981 Feb; 28(1):30-5. PubMed ID: 6265632
[No Abstract] [Full Text] [Related]
20. Leishmaniasis in the Sudan: a literature review with emphasis on clinical aspects.
Osman OF; Kager PA; Oskam L
Trop Med Int Health; 2000 Aug; 5(8):553-62. PubMed ID: 10995097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
